Vitamin D Test: What Level Is Actually Deficient and Who Needs Testing

The finger-prick kit arrives in a small cardboard box, the social post says “know your number,” and by the end of the week half the office is comparing results in the break room. That scene is playing out everywhere right now. As of March 2026, searches for a vitamin D test have climbed sharply, pushed by at-home kits, lab-direct ordering and a steady drumbeat of influencer claims that fatigue, hair thinning and low mood all trace back to one missing vitamin.

What makes this moment unusual is that the medical world has moved in the opposite direction. In June 2024 the Endocrine Society, the group that once popularized the 30 ng/mL target, stopped recommending routine blood testing for healthy adults under 75. The US Preventive Services Task Force still rates screening in people without symptoms as having insufficient evidence either way.

So two currents are colliding: more people than ever testing, and fewer experts than ever convinced it helps most of them. This piece sorts out which number actually means deficient, who genuinely benefits from a test, and what the trials really show.

Why is the vitamin D test suddenly everywhere?

Three things happened at once. Direct-to-consumer laboratories began letting people order a 25-hydroxyvitamin D test without a visit to a clinician. Mail-in finger-prick kits that return a number within days went mainstream. And short-form video turned “low vitamin D” into a catch-all explanation for tiredness, winter blues, slow workouts and brittle nails.

The appeal is understandable. Vitamin D is one of the few nutrients where a single blood value looks like a clean verdict, and the deficiency really is common. In US survey data from the NIH Office of Dietary Supplements, roughly one in four adults has levels in the inadequate range for bone health, and about 1 in 20 falls into the frankly deficient band. Those are not trivial numbers.

The trouble is what happens next. A value that reads “insufficient” on one laboratory’s report would read “normal” at another, because the cutoffs themselves are disputed. People then start supplements they may not need, retest a few weeks later, see little change and conclude the test was wrong. Clinicians, meanwhile, have watched test volumes rise several-fold over 15 years with no matching fall in fractures.

None of this means the vitamin D test is useless. For the right person, it changes management: it can explain bone pain, flag a malabsorption problem or catch toxicity in someone taking high-strength products. The skill lies in knowing when a number will actually alter a decision. The rest of this article is built around that single question.

What changed recently

The most consequential shift came on June 3, 2024, when the Endocrine Society published a new clinical practice guideline on vitamin D for disease prevention. Its 2011 version had defined deficiency as below 20 ng/mL and sufficiency as 30 ng/mL or above, cutoffs that spread onto laboratory reports worldwide. The 2024 guideline withdrew that framework. It now recommends against routine 25-hydroxyvitamin D testing in generally healthy adults under 75, including those with obesity or darker skin, and against treating to any specific blood target, because trials did not show that chasing a number improved outcomes.

Behind that reversal sits the VITAL trial, a randomized study of more than 25,000 US adults aged 50 and over. Its 2022 fracture analysis, summarized by Harvard Health, found that daily vitamin D supplementation did not reduce total, non-vertebral or hip fractures compared with placebo in people who were not selected for low levels. Earlier VITAL reports had already found no reduction in cancer or cardiovascular events as primary outcomes.

The US Preventive Services Task Force reaffirmed its position in 2021: insufficient evidence to recommend for or against screening asymptomatic adults, a so-called I statement that still stands. The NIH Office of Dietary Supplements fact sheet, updated most recently in 2024, keeps the Institute of Medicine framework: below 12 ng/mL deficient, 12 to 20 ng/mL potentially inadequate, 20 ng/mL and above adequate.

Put together, the dated picture looks like this: 2011, a broad call to test and treat to 30 ng/mL; 2021, screening evidence judged insufficient; 2022, the largest trial finds no fracture benefit in unselected adults; 2024, the original guideline authors step back from routine testing. Lab-report ranges have been slower to catch up, which is why many people still see a “low” flag that current guidance would not act on.

What does vitamin D do for the body?

Vitamin D is less a vitamin than a hormone precursor. Skin makes it when ultraviolet B light hits a cholesterol derivative; smaller amounts come from oily fish, egg yolks, fortified milk and supplements. The liver converts it to 25-hydroxyvitamin D, the storage form that circulates for weeks. The kidneys then make the active hormone, 1,25-dihydroxyvitamin D, in response to parathyroid hormone, a messenger released when blood calcium dips.

The active hormone’s best-documented job is to raise calcium absorption in the gut. With adequate vitamin D, the intestine absorbs roughly 30 to 40 percent of dietary calcium; without it, absorption can fall to 10 to 15 percent. The body then pulls calcium out of bone to keep blood levels steady. Over months that produces soft, poorly mineralized bone: rickets in growing children, with bowed legs and delayed growth, and osteomalacia in adults, which shows up as deep bone ache and proximal muscle weakness.

Beyond bone, vitamin D receptors sit in immune cells, muscle, the pancreas and blood vessels, which explains the long list of conditions it has been linked to in observational studies: respiratory infections, autoimmune disease, diabetes, depression, heart disease and several cancers. Linkage is not causation. People with low levels tend to be older, heavier, less active and spend less time outdoors, all of which independently raise disease risk.

Randomized trials have tested many of these associations and, for most, found little or no effect of supplementation in people who were not deficient to begin with. The exceptions are narrow and bone-related. That gap between association and proof is the single most useful fact to carry into any conversation about a vitamin D test.

What does a 25 hydroxy vitamin d test actually measure?

When a clinician orders a vitamin D test, almost always the laboratory measures total 25-hydroxyvitamin D, written 25(OH)D. It is the right marker for a simple reason: it reflects both sun exposure and intake over the previous two to three weeks, because its half-life in blood is around 15 days. The active hormone, 1,25-dihydroxyvitamin D, is a poor screening marker. Its half-life is only a few hours, and the kidneys hold it in the normal range right up until deficiency is severe, sometimes pushing it higher as parathyroid hormone rises.

Two sub-forms make up the total. Vitamin D3 (cholecalciferol) is what skin produces and what most supplements contain. Vitamin D2 (ergocalciferol) comes from plants and fungi and from some prescription products. A report labelled “fractionated” lists D2 and D3 separately, which mostly matters for people on D2-containing prescriptions. For everyone else the total is what counts.

The sample is an ordinary venous blood draw, no fasting needed, although some laboratories prefer the tube be kept out of direct light. Results come back in nanograms per milliliter (ng/mL) in the US and nanomoles per liter (nmol/L) in most other countries; multiply ng/mL by 2.5 to convert.

A 1,25-dihydroxyvitamin D test does have a place, but it is a specialist one: suspected kidney-related bone disease, certain inherited rickets, unexplained high calcium, or granulomatous conditions such as sarcoidosis where immune cells make the active hormone on their own. If a consumer panel offers it as an upgrade for general wellness, that is a signal to be cautious rather than impressed.

What vitamin D level is actually deficient?

Here is where the confusion lives, so the table below lays the main frameworks side by side.

Framework	Deficient	Inadequate or insufficient	Adequate	Potentially harmful
NIH / Institute of Medicine (US)	Below 12 ng/mL (30 nmol/L)	12 to under 20 ng/mL (30 to 50 nmol/L)	20 ng/mL (50 nmol/L) and above	Above 50 ng/mL (125 nmol/L)
NHS (UK)	Below 10 ng/mL (25 nmol/L)	10 to 20 ng/mL (25 to 50 nmol/L)	Above 20 ng/mL (50 nmol/L)	Toxicity typically above 150 ng/mL (375 nmol/L) with high calcium
Endocrine Society 2011 (now withdrawn)	Below 20 ng/mL (50 nmol/L)	20 to 29 ng/mL (50 to 74 nmol/L)	30 ng/mL (75 nmol/L) and above	Above 100 ng/mL (250 nmol/L)

The honest reading: below 12 ng/mL is deficient by any standard, and this is the range where rickets and osteomalacia occur. Between 12 and 20 ng/mL, bone turnover markers and parathyroid hormone begin to shift in some people, which is why the NIH calls it “potentially inadequate” rather than deficient. Above 20 ng/mL, 97.5 percent of the population meets bone needs according to the Institute of Medicine’s analysis, and trials have not shown added benefit from pushing to 30 or 40.

The 30 ng/mL target that still appears on many reports came from the 2011 Endocrine Society document and from observational studies where parathyroid hormone seemed to plateau around that point. Its own authors no longer endorse treating to it. If a report flags 24 ng/mL as “insufficient,” that reflects a laboratory reference range, not a diagnosis.

At the other end, concern begins above 50 ng/mL because observational data have linked levels that high with more falls, higher mortality and pancreatic cancer in some cohorts; those associations are weak and unproven, but they argue against treating a higher number as automatically better.

Who needs a vitamin d deficiency test?

Guideline bodies broadly agree on a targeted list. A vitamin D test is worth doing when the result could explain a problem or change treatment.

• Bone disease: osteoporosis, a fragility fracture (a break from a fall at standing height or less), osteomalacia or rickets, or unexplained bone pain with raised alkaline phosphatase, a bone-turnover enzyme.
• Malabsorption: celiac disease, Crohn’s disease, cystic fibrosis, chronic pancreatitis, short bowel, or previous bariatric surgery, all of which reduce absorption of fat-soluble vitamins.
• Chronic kidney disease, which impairs conversion to the active hormone and disturbs calcium and phosphate handling; and advanced liver disease, which impairs the first conversion step.
• Abnormal calcium, phosphate or parathyroid hormone results, including hyperparathyroidism, where vitamin D status affects interpretation and management.
• Medicines that speed vitamin D breakdown or block absorption: certain anti-seizure drugs, long-term glucocorticoids, some antifungal and HIV medicines, cholestyramine and orlistat.
• Granulomatous diseases such as sarcoidosis or tuberculosis, where levels guide safety as much as sufficiency.
• Suspected toxicity in someone taking high-strength products, especially with nausea, thirst or confusion.

Older adults who are housebound or in long-term care, people with very limited sun exposure such as those who cover skin for cultural reasons, and people with darker skin living at high latitude carry a higher prevalence of low levels. Here guidance diverges: the NHS and many clinicians favor simply advising a daily supplement in these groups without testing, while some will test if there is also a fall, fracture or symptom. Pregnancy and childhood deficiency are managed in most guidelines through routine supplementation rather than screening.

The pattern is clear. Testing earns its place when the number will drive a decision about bone, absorption, kidney function or safety, not as a general health audit.

Who probably does not need a vitamin D test?

A healthy adult under 75 with no symptoms, no bone disease and no absorption problem is the person the current guidelines say not to test routinely. That recommendation sounds counterintuitive given how common low levels are, so it helps to understand the reasoning.

Screening only makes sense when finding and correcting a problem improves outcomes. For vitamin D the randomized trials have been remarkably consistent: in unselected community adults, supplementation did not lower rates of fracture, cancer, heart disease, diabetes, depression or respiratory infection as primary endpoints. If treatment does not help the average screened person, then the test that leads to that treatment cannot help either. This is the logic behind the USPSTF’s I statement and the Endocrine Society’s 2024 change.

There is also a practical cost in the non-financial sense. Laboratory assays vary by 10 to 20 percent between methods, so a person at 19 ng/mL in one laboratory may be 23 in another. Values swing with season; late-winter readings in the northern US run several ng/mL below late-summer ones. A single number can therefore create a diagnosis that was never really there, followed by supplements, repeat tests and anxiety.

None of this applies to people with symptoms or risk conditions, and it does not stop a clinician from testing a particular patient for a particular reason. It also does not argue against a modest daily supplement for groups the NHS and NIH already identify as likely to run low during winter; that advice stands on its own, test or no test. What the evidence does not support is the “everyone should know their number” message that is currently driving search traffic.

How to test for high vitamin D

High vitamin D is rarer than low, but the rise of high-strength products and stacking several supplements that each contain it has made toxicity a real clinical presentation again. The test is the same 25-hydroxyvitamin D measurement. Toxicity is a laboratory diagnosis built from three results read together, not a single value.

First, the 25(OH)D level itself. Sun exposure alone will not cause toxicity because skin production self-limits; excess comes from supplements. Levels above 150 ng/mL (375 nmol/L) are the usual threshold where harm appears, although the NIH flags anything above 50 ng/mL as a reason to review intake.

Second, blood calcium, ideally corrected for albumin or measured as ionized calcium. The damage from too much vitamin D is done by hypercalcemia, a high blood calcium that causes nausea, vomiting, constipation, excessive thirst and urination, weakness, confusion and, if sustained, kidney stones and kidney injury. A high 25(OH)D with normal calcium is a warning to stop the excess; a high 25(OH)D with high calcium is a medical problem that needs prompt management.

Third, parathyroid hormone, which should be suppressed when vitamin D and calcium are high. If it is not, the clinician will look for a parathyroid cause instead. Kidney function tests and sometimes a 1,25-dihydroxyvitamin D level complete the picture, particularly when sarcoidosis or lymphoma are possible.

Because 25(OH)D is stored in fat and has a long half-life, levels can stay elevated for weeks to months after stopping a supplement, so repeat testing is spaced out and timed by the treating clinician. Anyone who suspects they have been taking too much should not simply wait it out; the combination of symptoms above warrants a same-week appointment.

Does the lab method matter? Immunoassay vs LC-MS/MS

Two technologies dominate. Immunoassays use antibodies that bind 25(OH)D and are fast, automated and cheap for laboratories to run, which is why most high-volume testing uses them. Liquid chromatography tandem mass spectrometry, written LC-MS/MS, separates molecules by weight and charge; it is the reference method, can report D2 and D3 separately and is less prone to interference.

The difference is not academic. Some immunoassays under-recognize vitamin D2, which matters for people on D2 prescriptions. Several also partly detect a related molecule, 3-epi-25(OH)D, which is abundant in infants and can inflate their results. Lipemic or hemolyzed samples and certain antibodies in the patient’s blood can skew immunoassays. Historic head-to-head studies found results could differ by 10 to 20 percent between platforms for the same sample, enough to move someone across the 20 ng/mL line.

The Vitamin D Standardization Program, run with the NIH Office of Dietary Supplements and the CDC, has narrowed that gap substantially. Laboratories that participate calibrate against reference materials, and the CDC’s certification program publishes which assays meet accuracy targets. Many major US laboratories now use standardized LC-MS/MS or certified immunoassays.

For a patient the practical rules are simple. Use the same laboratory for any repeat test so that changes reflect the body rather than the method. Treat a value within a few ng/mL of a cutoff as borderline, not as a verdict. And if a result seems out of line with the clinical picture, a clinician can request confirmation by LC-MS/MS. The method rarely needs to be chosen by the patient, but knowing why two reports disagree saves a lot of unnecessary worry.

At-home vitamin D test kits and rapid cassettes: how reliable are they?

Two kinds of consumer products are driving the trend, and they are not equal.

Mail-in dried blood spot kits involve pricking a fingertip, dropping blood onto a card and posting it to a laboratory, which usually analyzes it by LC-MS/MS. Validation studies have found dried blood spot 25(OH)D correlates well with venous serum, typically within about 10 to 15 percent, although hematocrit (the proportion of red cells) and how fully the spot is filled affect accuracy. A well-run kit gives a reasonable estimate. It still inherits every interpretive problem described above: disputed cutoffs, seasonal swing and a report that may flag “insufficient” at a level current guidelines would leave alone.

Rapid cassette tests work differently. They are lateral-flow strips, the same technology as a home pregnancy test, and most give a semi-quantitative result: a color band read against a chart as deficient, insufficient or sufficient. Independent data on their accuracy are limited, reading a faint band is subjective, and they cannot distinguish 24 from 32 ng/mL with confidence. They are best regarded as a rough indicator rather than a diagnostic test.

Both products share a blind spot. They report a vitamin D value in isolation, with no calcium, parathyroid hormone, kidney function or clinical history alongside it. The groups who most need testing, people with malabsorption, bone disease or kidney disease, are precisely those for whom that context changes the meaning of the result.

Anyone who has already used a kit and received a low or high value should bring the printout to a clinician rather than act on it alone. A standardized venous test, ordered because of a real indication and read against the whole picture, remains the version that actually guides care.

How to read vitamin D blood test results

A report usually shows the value, the unit and a reference range with a flag. Four details change how to read it.

Units come first. 50 nmol/L and 20 ng/mL are the same level; mixing them up is the most common error in online self-interpretation and it produces either false alarm or false reassurance by a factor of 2.5.

Season comes second. In the continental US, 25(OH)D peaks in August and September and troughs in February and March, with a typical swing of 5 to 10 ng/mL. A February reading of 18 ng/mL in someone who is active outdoors in summer tells a different story from the same value in July.

Timing of recent intake comes third. Because 25(OH)D has a two-week half-life, blood reflects the past month or two. A test taken within a few weeks of starting a supplement will not yet show the full effect; clinicians therefore schedule any repeat test months later, and the interval is their call, not a kit’s.

Context comes fourth, and matters most. A level of 15 ng/mL with normal calcium, no symptoms and winter timing in a healthy adult points toward ordinary seasonal lowness. The same level in someone with a recent fragility fracture, celiac disease or bone pain and a raised alkaline phosphatase is a finding that needs treatment. A level of 60 ng/mL in someone taking several supplements calls for a review of intake and a calcium check.

Reference ranges on reports are set by laboratories and often still display the 30 ng/mL sufficiency line. Read the number against the frameworks in the table above, then let the prescribing clinician decide what, if anything, to do.

What the evidence actually says about vitamin D testing and supplementation

Grading the evidence by strength clears a lot of noise.

Strong, from randomized trials: treating true deficiency prevents and reverses rickets and osteomalacia; combined vitamin D and calcium modestly reduce hip and non-vertebral fractures in older, institutionalized or deficient adults; in people with adequate levels, supplementation does not reduce fractures (VITAL, 2022), cancer incidence, cardiovascular events, or type 2 diabetes progression as primary outcomes. The large D-Health trial in Australia likewise found no mortality benefit.

Moderate: meta-analyses of randomized trials suggest a small reduction in acute respiratory infections with regular daily dosing, concentrated in people who started very deficient; the effect is modest and absent in several newer trials. Trials in people with prediabetes show a small reduction in progression to diabetes in pooled analysis, enough for the 2024 Endocrine Society guideline to mention it, but not large enough to change screening advice.

Weak, observational only: associations between low 25(OH)D and depression, autoimmune disease, dementia, severe COVID-19, all-cause mortality and many cancers. These are real statistical links but are heavily confounded by age, body weight, illness, and time spent outdoors, and the randomized trials that followed have mostly been negative.

Expert opinion: which cutoff to call deficient, whether to test high-risk groups or just supplement them, and how often to repeat testing. These are judgment calls, which is why guidelines differ.

Where does that leave the vitamin D test? Its value is highest where the strong evidence applies: diagnosing and monitoring bone disease and malabsorption, and detecting toxicity. Its value is lowest where the weak evidence lives: hunting for a cause of general tiredness in an otherwise healthy person. That asymmetry, not enthusiasm or skepticism, should drive the decision to test.

Common myths about the vitamin D test

“Everyone should check their level once a year.” No major guideline recommends this. For healthy adults without symptoms or risk conditions, the Endocrine Society advises against routine testing and the USPSTF finds insufficient evidence. Testing has value when a result would change management.

“Below 30 ng/mL means I’m deficient.” That cutoff was an insufficiency threshold from a 2011 guideline whose authors withdrew it in 2024. The NIH considers 20 ng/mL and above adequate for bone health in nearly everyone; deficiency by any standard begins below 12 ng/mL.

“Higher is always better.” Trials show no added benefit above the adequate range, and observational data link levels above 50 ng/mL to more falls and other harms. Toxicity with high calcium is well documented at very high levels.

“My tiredness or hair loss proves I’m low.” Fatigue, low mood and hair shedding have dozens of causes. Most trials of supplementation in people who were not deficient found no effect on energy or mood. A test can rule deficiency in or out; it cannot prove it is the cause.

“Dark skin or living up north means I must be tested.” These raise the chance of low levels, which is why the NHS and others suggest a routine daily supplement in winter for people at risk. Guidelines favor that simple step over testing unless symptoms or disease are present.

“A rapid home strip is as good as a lab test.” Lateral-flow cassettes give a rough category, not a precise value, and lack supporting data. Mail-in dried blood spot kits are closer to laboratory accuracy but still lack the calcium and clinical context that give the number meaning.

“Sunlight can push me into toxicity.” Skin production is self-limiting. Toxicity comes from supplements, almost always in high strengths taken over time.

When to see a doctor

A vitamin D test is a decision that belongs with a clinician who knows your history, and some situations should not wait for a routine appointment.

Seek prompt medical advice if you have persistent deep bone pain, especially in the hips, pelvis, ribs or lower back; muscle weakness that makes it hard to climb stairs or rise from a chair; a fracture after a minor fall; or, in a child, bowed legs, delayed walking or poor growth. These can signal osteomalacia or rickets and need proper evaluation, not a home kit.

Treat the following as red flags that need same-day or urgent care, because they can indicate high blood calcium from vitamin D excess or another cause: repeated vomiting, severe constipation, intense thirst with frequent urination, confusion or unusual drowsiness, palpitations, or severe flank pain that could mean a kidney stone. Mention every supplement and the strengths you take.

Book a non-urgent appointment if you have a condition on the testing list, such as celiac disease, inflammatory bowel disease, kidney or liver disease, previous bariatric surgery or a diagnosis of osteoporosis, and have never had your level checked; if you take long-term anti-seizure medicine, glucocorticoids or other drugs that affect vitamin D; if you are pregnant or planning pregnancy and unsure about supplementation; or if a consumer kit has returned a very low or very high value.

Never stop, start or change a prescribed vitamin D or calcium product on the strength of a test result alone, including a prescription written for another condition. Levels need to be read alongside calcium, kidney function and symptoms, and only the prescribing clinician can weigh those together. If a result worries you, the right next step is a conversation, not a change to the medicine cabinet.

Frequently asked questions

How can you test for vitamin D deficiency?

A blood test for 25-hydroxyvitamin D is the standard way to check vitamin D status. It is a routine venous draw with no fasting required, usually ordered by a clinician when bone disease, malabsorption, kidney or liver disease, certain medicines or symptoms make deficiency likely. Mail-in finger-prick kits estimate the same value with reasonable accuracy but lack the calcium and clinical context needed to interpret it.

How to test for high vitamin D?

High vitamin D is assessed with the same 25-hydroxyvitamin D blood test, read together with blood calcium, parathyroid hormone and kidney function. Toxicity is usually seen above 150 ng/mL (375 nmol/L) and matters when calcium is also raised, producing nausea, thirst, frequent urination or confusion. Because the vitamin is stored in fat, levels fall slowly after stopping a supplement, so repeat testing is spaced out by the clinician.

What does vitamin D do for the body?

Vitamin D’s proven role is to raise calcium absorption in the gut, roughly doubling it compared with a deficient state, which keeps bone properly mineralized and prevents rickets in children and osteomalacia in adults. Receptors also exist in immune, muscle and vascular tissue, which explains many observational links to other diseases, but randomized trials have mostly not confirmed benefits outside bone in people who were not deficient.

How much does a vitamin D 25 hydroxy test cost?

Costs vary widely depending on the laboratory, the test method, whether a clinician orders it for a medical indication and how insurance handles it, so no single figure applies. When a test is ordered for a recognized reason such as bone disease or malabsorption, it is commonly covered; consumer-ordered tests are usually paid out of pocket. Your clinician’s office or the laboratory can confirm what applies to you.

What is a normal vitamin D blood test result?

A result of 20 ng/mL (50 nmol/L) or higher is considered adequate for bone health by the NIH and the Institute of Medicine, and the NHS uses the same line. Many laboratories still print 30 ng/mL as the sufficiency cutoff, a figure from a 2011 guideline that has since been withdrawn. Results above 50 ng/mL (125 nmol/L) are high enough to review supplement intake.

What is the difference between a vitamin D 25-hydroxy test and a 1,25-dihydroxy test?

The 25-hydroxy test measures the storage form and is the right test for assessing vitamin D status, because it reflects sun and intake over the previous few weeks. The 1,25-dihydroxy test measures the short-lived active hormone, which the kidneys keep normal even in deficiency. It is reserved for specialist situations such as kidney disease, inherited rickets, sarcoidosis or unexplained high calcium.

Does the time of year affect vitamin D blood test results?

Yes. In the United States, 25-hydroxyvitamin D typically peaks in late summer and reaches its lowest point in February and March, with a seasonal swing of about 5 to 10 ng/mL for many people. A borderline winter value can therefore look normal by midsummer. Clinicians take season into account when deciding whether a result reflects a persistent problem.

Do you need to fast before a vitamin D test?

No fasting is needed for a 25-hydroxyvitamin D test, and it can be drawn at any time of day. If other tests such as glucose or lipids are being taken at the same visit, those may require fasting, so follow the instructions given for the whole panel. Tell the clinician about any vitamin D supplements, including multivitamins and fortified products, so the result can be interpreted correctly.

Are at-home vitamin D test kits accurate?

Mail-in dried blood spot kits analyzed by a laboratory generally agree with venous results to within roughly 10 to 15 percent, which is acceptable for an estimate. Rapid lateral-flow cassette strips give only a rough category and have little independent validation. Neither includes calcium, parathyroid hormone or clinical history, so a low or high result should be confirmed and interpreted by a clinician.

How often should vitamin D levels be checked?

For healthy adults without symptoms or risk conditions, current guidelines do not recommend routine or repeated testing at all. For people being treated for deficiency or monitored for conditions such as osteoporosis, malabsorption or kidney disease, the interval is set by the treating clinician and usually spans months, because 25-hydroxyvitamin D changes slowly. Ask your clinician what schedule, if any, fits your situation.

References

• Vitamin D Test, MedlinePlus
• Vitamin D, NHS

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.